These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24226465)

  • 1. Reverse Fox test for detecting visuospatial dysfunction corresponding to parietal hypoperfusion in mild Alzheimer's disease.
    Tabuchi H; Konishi M; Saito N; Kato M; Mimura M
    Am J Alzheimers Dis Other Demen; 2014 Mar; 29(2):177-82. PubMed ID: 24226465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain perfusion correlates of visuoperceptual deficits in mild cognitive impairment and mild Alzheimer's disease.
    Alegret M; Vinyes-Junqué G; Boada M; Martínez-Lage P; Cuberas G; Espinosa A; Roca I; Hernández I; Valero S; Rosende-Roca M; Mauleón A; Becker And JT; Tárraga L
    J Alzheimers Dis; 2010; 21(2):557-67. PubMed ID: 20555146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease.
    Nobili F; Brugnolo A; Calvini P; Copello F; De Leo C; Girtler N; Morbelli S; Piccardo A; Vitali P; Rodriguez G
    Clin Neurophysiol; 2005 Feb; 116(2):364-75. PubMed ID: 15661114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain perfusion abnormalities in Alzheimer's disease: comparison between patients with focal temporal lobe dysfunction and patients with diffuse cognitive impairment.
    Cappa A; Calcagni ML; Villa G; Giordano A; Marra C; De Rossi G; Puopolo M; Gainotti G
    J Neurol Neurosurg Psychiatry; 2001 Jan; 70(1):22-7. PubMed ID: 11118243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.
    Johnson NA; Jahng GH; Weiner MW; Miller BL; Chui HC; Jagust WJ; Gorno-Tempini ML; Schuff N
    Radiology; 2005 Mar; 234(3):851-9. PubMed ID: 15734937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlations between brain SPECT and neuropsychology assessments in mild and moderate stages of Alzheimer's disease].
    Arbizu J; Larumbe R; Gámez C; Martí J; Martínez-Lage J; Richter J
    Rev Esp Med Nucl; 1999 Aug; 18(4):252-60. PubMed ID: 10481106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional cerebral blood flow measured by 99mTc-HMPAO SPECT differs in subgroups of Alzheimer's disease.
    Soininen H; Helkala EL; Kuikka J; Hartikainen P; Lehtovirta M; Riekkinen PJ
    J Neural Transm Park Dis Dement Sect; 1995; 9(2-3):95-109. PubMed ID: 8527009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain SPECT in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study.
    Nobili F; Frisoni GB; Portet F; Verhey F; Rodriguez G; Caroli A; Touchon J; Calvini P; Morbelli S; De Carli F; Guerra UP; Van de Pol LA; Visser PJ
    J Neurol; 2008 Sep; 255(9):1344-53. PubMed ID: 18958573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unawareness of memory deficits depending on cerebral perfusion pattern in mild cognitive impairment.
    Hanyu H; Sakurai H; Hirao K; Shimizu S; Iwamoto T
    J Am Geriatr Soc; 2007 Mar; 55(3):470-1. PubMed ID: 17341256
    [No Abstract]   [Full Text] [Related]  

  • 10. Alteration of rCBF in Alzheimer's disease patients with delusions of theft.
    Fukuhara R; Ikeda M; Nebu A; Kikuchi T; Maki N; Hokoishi K; Shigenobu K; Komori K; Tanabe H
    Neuroreport; 2001 Aug; 12(11):2473-6. PubMed ID: 11496132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Entorhinal Tau Predicts Hippocampal Activation and Memory Deficits in Alzheimer's Disease.
    Richter N; Bischof GN; Dronse J; Nellessen N; Neumaier B; Langen KJ; Drzezga A; Fink GR; van Eimeren T; Kukolja J; Onur OA
    J Alzheimers Dis; 2020; 78(4):1601-1614. PubMed ID: 33164934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of different parietal hypoperfusion on neuropsychological characteristics in mild cognitive impairment.
    Yamaguchi T; Tabuchi H; Ito D; Saito N; Yamagata B; Konishi M; Takebayashi M; Ikeda M; Mimura M
    Psychogeriatrics; 2021 Jul; 21(4):618-626. PubMed ID: 34056807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPECT predictors of cognitive decline and Alzheimer's disease in mild cognitive impairment.
    Nobili F; De Carli F; Frisoni GB; Portet F; Verhey F; Rodriguez G; Caroli A; Touchon J; Morbelli S; Guerra UP; Dessi B; Brugnolo A; Visser PJ
    J Alzheimers Dis; 2009; 17(4):761-72. PubMed ID: 19542623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anosognosia in mild Alzheimer's disease is correlated with not only neural dysfunction but also compensation.
    Tagai K; Shinagawa S; Kada H; Inamura K; Nagata T; Nakayama K
    Psychogeriatrics; 2018 Mar; 18(2):81-88. PubMed ID: 29409154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional cerebral blood flow abnormalities in nondemented patients with memory impairment.
    Tanaka M; Fukuyama H; Yamauchi H; Narita M; Nabatame H; Yokode M; Fujimoto N; Kita T; Murakami M
    J Neuroimaging; 2002 Apr; 12(2):112-8. PubMed ID: 11977904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bihemispheric cerebral FDG PET correlates of cognitive dysfunction as assessed by the CERAD in Alzheimer's disease.
    Schönknecht OD; Hunt A; Toro P; Guenther T; Henze M; Haberkorn U; Schröder J
    Clin EEG Neurosci; 2011 Apr; 42(2):71-6. PubMed ID: 21675596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT.
    Hirao K; Ohnishi T; Hirata Y; Yamashita F; Mori T; Moriguchi Y; Matsuda H; Nemoto K; Imabayashi E; Yamada M; Iwamoto T; Arima K; Asada T
    Neuroimage; 2005 Dec; 28(4):1014-21. PubMed ID: 16129627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Neuropsychological Correlates of Brain Perfusion and Gray Matter Volume in Alzheimer's Disease.
    Tai H; Hirano S; Sakurai T; Nakano Y; Ishikawa A; Kojima K; Li H; Shimada H; Kashiwado K; Mukai H; Horikoshi T; Sugiyama A; Uno T; Kuwabara S
    J Alzheimers Dis; 2020; 78(4):1639-1652. PubMed ID: 33185599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two distinct pathological substrates associated with MMSE-pentagons item deficit in DLB and AD.
    Beretta L; Caminiti SP; Santangelo R; Magnani G; Ferrari-Pellegrini F; Caffarra P; Perani D
    Neuropsychologia; 2019 Oct; 133():107174. PubMed ID: 31446008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (99m)Tc hexamethyl-propylene-aminoxime single-photon emission computed tomography prediction of conversion from mild cognitive impairment to Alzheimer disease.
    Devanand DP; Van Heertum RL; Kegeles LS; Liu X; Jin ZH; Pradhaban G; Rusinek H; Pratap M; Pelton GH; Prohovnik I; Stern Y; Mann JJ; Parsey R
    Am J Geriatr Psychiatry; 2010 Nov; 18(11):959-72. PubMed ID: 20808143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.